Follow
Sean Hays
Sean Hays
Unknown affiliation
Verified email at summittoxicology.com
Title
Cited by
Cited by
Year
Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective
SM Hays, RA Becker, HW Leung, LL Aylward, DW Pyatt
Regulatory Toxicology and Pharmacology 47 (1), 96-109, 2007
2602007
Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework
RS Thomas, MA Philbert, SS Auerbach, BA Wetmore, MJ Devito, I Cote, ...
toxicological sciences 136 (1), 4-18, 2013
2572013
Dioxin risks in perspective: past, present, and future
SM Hays, LL Aylward
Regulatory Toxicology and Pharmacology 37 (2), 202-217, 2003
1872003
Human biomonitoring assessment values: approaches and data requirements
J Angerer, LL Aylward, SM Hays, B Heinzow, M Wilhelm
International journal of hygiene and environmental health 214 (5), 348-360, 2011
1852011
A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects
JS Lakind, ST Holgate, DR Ownby, AH Mansur, PJ Helms, D Pyatt, ...
Biomarkers 12 (5), 445-467, 2007
1812007
Sources of variability in biomarker concentrations
LL Aylward, SM Hays, R Smolders, HM Koch, J Cocker, K Jones, ...
Journal of Toxicology and Environmental Health, Part B 17 (1), 45-61, 2014
1742014
Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact …
LL Aylward, RC Brunet, G Carrier, SM Hays, CA Cushing, LL Needham, ...
Journal of Exposure Science & Environmental Epidemiology 15 (1), 51-65, 2005
1732005
Guidelines for the derivation of biomonitoring equivalents: report from the biomonitoring equivalents expert workshop
SM Hays, LL Aylward, JS LaKind, MJ Bartels, HA Barton, PJ Boogaard, ...
Regulatory Toxicology and Pharmacology 51 (3), S4-S15, 2008
1702008
Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation
HA Barton, WA Chiu, R Woodrow Setzer, ME Andersen, AJ Bailer, ...
Toxicological Sciences 99 (2), 395-402, 2007
1552007
Asthma and swimming: a meta-analysis
M Goodman, S Hays
Journal of Asthma 45 (8), 639-647, 2008
1502008
Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicals
LL Aylward, CR Kirman, R Schoeny, CJ Portier, SM Hays
Environmental health perspectives 121 (3), 287-294, 2013
1392013
A chronic oral reference dose for hexavalent chromium‐induced intestinal cancer
CM Thompson, CR Kirman, DM Proctor, LC Haws, M Suh, SM Hays, ...
Journal of Applied Toxicology 34 (5), 525-536, 2014
1282014
Temporal trends in human TCDD body burden: decreases over three decades and implications for exposure levels
LL Aylward, SM Hays
Journal of Exposure Science & Environmental Epidemiology 12 (5), 319-328, 2002
1242002
Inter-and intra-individual variation in urinary biomarker concentrations over a 6-day sampling period. Part 2: personal care product ingredients
HM Koch, LL Aylward, SM Hays, R Smolders, RK Moos, J Cocker, ...
Toxicology letters 231 (2), 261-269, 2014
1182014
Variation in urinary flow rates according to demographic characteristics and body mass index in NHANES: potential confounding of associations between health outcomes and …
SM Hays, LL Aylward, BC Blount
Environmental health perspectives 123 (4), 293-300, 2015
1132015
Biomonitoring equivalents (BE) dossier for cadmium (Cd)(CAS No. 7440-43-9)
SM Hays, M Nordberg, JW Yager, LL Aylward
Regulatory toxicology and pharmacology 51 (3), S49-S56, 2008
1092008
Relationships of chemical concentrations in maternal and cord blood: a review of available data
LL Aylward, SM Hays, CR Kirman, SA Marchitti, JF Kenneke, C English, ...
Journal of Toxicology and Environmental Health, Part B 17 (3), 175-203, 2014
1002014
Using biomonitoring equivalents to interpret human biomonitoring data in a public health risk context
SM Hays, LL Aylward
Journal of Applied Toxicology 29 (4), 275-288, 2009
1002009
Biomonitoring equivalents for inorganic arsenic
SM Hays, LL Aylward, M Gagné, A Nong, K Krishnan
Regulatory Toxicology and Pharmacology 58 (1), 1-9, 2010
952010
Interpreting variability in population biomonitoring data: role of elimination kinetics
LL Aylward, CR Kirman, JL Adgate, LM McKenzie, SM Hays
Journal of exposure science & environmental epidemiology 22 (4), 398-408, 2012
932012
The system can't perform the operation now. Try again later.
Articles 1–20